Document is current
Any future updates will be listed below
-
Authors
Lim, Kyung Ho
Kang, Ujin
Li, Xiang
Kim, Jin Sung
Jung, Young-Chul
Park, Sangjoon https://orcid.org/0000-0002-9223-3172
Kim, Byung-Hoon https://orcid.org/0000-0003-2501-038X
-
Funding
Funding for this research was provided by:
Severance Hospital Research fund for Clinical excellenc (C-2024-0041)
Bio&Medical Technology Development Program of the National Research Foundation (MSIT; RS-2024- 00509289)
- License Information
-
More Information
Article History
Received: 2 April 2025
Revised: 2 October 2025
Accepted: 6 October 2025
First Online: 1 December 2025
Declarations
:
: The clinician evaluation component of this study was approved by the Institutional Review Board of Severance Hospital, Yonsei University Health System (IRB No. 4–2025-0714). All clinician raters participated voluntarily after being informed of the study’s purpose and procedure.
: Not applicable.
: J.S.K. is a shareholder and employee of Oncosoft Inc., which could potentially benefit from the research findings presented in this paper. This conflict of interest has been disclosed and managed in accordance with institutional policies. B.-H.K. is a shareholder and outside board member of EverEx, which could potentially benefit from this study. The other authors have no competing interests to declare.
: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
